the effect of desmopressin on the amount of bleeding in patients undergoing coronary artery bypass graft surgery with a cardiopulmonary bypass pump after taking anti-platelet medicine

conclusions our study showed that desmopressin could not reduce the amount of blood loss after cabg. also, desmopressin did not have a significant effect on coagulation status. therefore, based on the results of our study, it seems that the use of this medication cannot be a helpful for patients with any indication for cabg. background coronary artery bypass grafting (cabg) is a common surgical intervention at the end-stages of coronary artery occlusion disease. despite the effectiveness of cabg, it may have particular complications, such as bleeding during and after surgery. so far, there have been many drugs used to reduce bleeding. objectives this study aimed at investigating the effects of desmopressin on the amount of bleeding in patients undergoing cabg with a cardiopulmonary bypass pump (cpbp) who were taking anti-platelet medicine. methods one hundred patients scheduled for elective cabg with a cpbp were included in a prospective, placebo-controlled, double-blinded clinical trial study. they were randomly divided into two groups. one group received desmopressin (40 μg) and the other group received a placebo (isotonic saline). seven patients were excluded from the study, and 47 and 46 patients participated in the desmopressin and control groups, respectively. the methods of monitoring and the anesthetic techniques were similar in both groups, and all surgeries were performed by one surgeon. variables including age, gender, pump time, aortic clamp time, duration of surgery, complications (e.g., nausea and vomiting, blood pressure changes), the necessity to receive blood products, and coagulation tests (prothrombin time, partial thromboplastin time, international normalized ratio, and bleeding time) were assessed. data were statistically analyzed with spss software version 17. results there was no significant difference between the groups regarding age, gender, pump time, clamp time, duration of surgery, complications, and the changes in hemoglobin and coagulation test measurements (p > 0.05). no significant difference was noted between the groups regarding the rate of bleeding after surgery (359.3 ± 266.2 in group d vs. 406.3 ± 341.6 in group p (control group); p = 0.208). however, the platelet changes after surgery in both groups were significantly different. the analysis revealed that the rate of thrombocytopenia after surgery was higher in the control group (p = 0.012).